Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Jieling, Xiao"'
Autor:
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
Publikováno v:
Clinical and Molecular Hepatology, Vol 28, Iss 3, Pp 483-496 (2022)
Background/Aims Non-alcoholic fatty liver disease (NAFLD) is associated with the development of cardiovascular disease. While existing studies have examined cardiac remodeling in NAFLD, there has been less emphasis on the development of carotid ather
Externí odkaz:
https://doaj.org/article/6b6d5630aac840db9fc0557d9bb72d6f
Autor:
Cheng Han Ng, Ansel Shao Pin Tang, Jieling Xiao, Zhen Yu Wong, Jie Ning Yong, Clarissa E. Fu, Rebecca W. Zeng, Caitlyn Tan, Gabriel Hong Zhe Wong, Margaret Teng, Douglas Chee, Darren Jun Hao Tan, Kai En Chan, Daniel Q. Huang, Nicholas W.S. Chew, Benjamin Nah, Mohammad S. Siddqui, Arun J. Sanyal, Mazen Noureddin, Mark Muthiah
Publikováno v:
Hepatology Communications, Vol 7, Iss 3, Pp e0005-e0005 (2023)
Background and Aims:. Obeticholic acid (OCA) is a farnesoid X receptor agonist used in primary biliary cholangitis (PBC) treatment. Recent studies have expanded OCA use for NASH treatment and results from phase 3 clinical trial have shown beneficial
Externí odkaz:
https://doaj.org/article/be1048244200477e96ed33185cb648c9
Autor:
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, Jieling Xiao, Jie Ning Yong, Bryan Tan, Nicholas Syn, Jiong-Wei Wang, Nilofer Sayed, Eunice Tan, Nicholas WS Chew, Yock Young Dan, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mazen Noureddin
Publikováno v:
Annals of Hepatology, Vol 28, Iss 1, Pp 100762- (2023)
ABSTRACT: Introduction and Objectives: Type 2 Diabetes Mellitus (T2DM) is comorbidity commonly presenting with fatty liver. A recently proposed definition of ''metabolic associated fatty liver disease'' (MAFLD) is thought to replace non-alcoholic fat
Externí odkaz:
https://doaj.org/article/0c881f16cfd748c5ac0a0664b7fc766d
Autor:
Cheng Han Ng, Jieling Xiao, Nicholas W. S. Chew, Yip Han Chin, Kai En Chan, Jingxuan Quek, Wen Hui Lim, Darren Jun Hao Tan, Ryan Wai Keong Loke, Caitlyn Tan, Ansel Shao Pin Tang, Xin Lei Goh, Benjamin Nah, Nicholas Syn, Dan Yock Young, Nobuharu Tamaki, Daniel Q. Huang, Mohammad Shadab Siddiqui, Mazen Noureddin, Arun Sanyal, Mark Muthiah
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background and aimsThe global prevalence of non-alcoholic fatty liver disease (NAFLD) is expected to rise continuously. Furthermore, emerging evidence has also shown the potential for concomitant depression in NAFLD. This study aims to examine the pr
Externí odkaz:
https://doaj.org/article/8eea24be9617447baaec8753cb81ac46
Autor:
Clarissa Elysia Fu, Cheng Han Ng, Nicholas W. S. Chew, Zane En Qi Heng, Yip Han Chin, Jingxuan Quek, Wen Hui Lim, Jieling Xiao, Kai En Chan, Darren Jun Hao Tan, Caitlyn Tan, Sitong Zhang, Teng Kiat Koh, Benjamin Nah, Yock Young Dan, Nicholas Syn, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mazen Noureddin, Mark Muthiah
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundNon-alcoholic fatty liver disease (NAFLD) is prevalent amongst overweight and obese individuals, and weight loss remains the main mode of treatment for NAFLD patients. Weight perception plays a key role in the efficacy of such treatment. Th
Externí odkaz:
https://doaj.org/article/8c607e87c5a54fbc8ebd4b388628dc40
Autor:
Cheng Han Ng, Zhen Yu Wong, Nicholas W. S. Chew, Kai En Chan, Jieling Xiao, Nilofer Sayed, Wen Hui Lim, Darren Jun Hao Tan, Ryan Wai Keong Loke, Phoebe Wen Lin Tay, Jie Ning Yong, Gywneth Kong, Daniel Q. Huang, Jiong-Wei Wang, Mark Chan, Mayank Dalakoti, Nobuharu Tamaki, Mazen Noureddin, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Background and aimsHypertension (HTN) is a common comorbidity in non-alcoholic fatty liver disease (NAFLD) affecting up to 40% of individuals. However, the impact of HTN and its control on outcomes in NAFLD remains unclear. Therefore, we aimed to exa
Externí odkaz:
https://doaj.org/article/9a1c9137945944688af14b7b461ed45f
Autor:
Darren Jun Hao Tan, Ansel Shao Pin Tang, Wen Hui Lim, Cheng Han Ng, Benjamin Nah, Clarissa Fu, Jieling Xiao, Benjamin Koh, Phoebe Wen Lin Tay, Eunice X Tan, Margaret Teng, Nicholas Syn, Mark D Muthiah, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Thomas Yau, Arndt Vogel, Rohit Loomba, Daniel Q. Huang
Publikováno v:
Liver Cancer, Pp 1-1 (2023)
Background: Emerging data suggest that outcomes for advanced hepatocellular carcinoma (HCC) treated with sorafenib may have improved over time. We aimed to provide robust, time-to-event estimates of survival outcomes for sorafenib in advanced HCC. Su
Externí odkaz:
https://doaj.org/article/c64d96b78c00470fbf7b3b42cad4312f
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/30a70ab4b3094d8198ba66078eb4fc7e
Autor:
Wen Hui Lim, Kai En Chan, Cheng Han Ng, Darren Jun Hao Tan, Phoebe Wen Lin Tay, Yip Han Chin, Jie Ning Yong, Jieling Xiao, Clarissa Elysia Fu, Benjamin Nah, Ho Yee Tiong, Nicholas Syn, Kamala Devi, Konstadina Griva, Loey Lung Yi Mak, Daniel Q Huang, James Fung, Mohammad Shadab Siddiqui, Mark Muthiah, Eunice X X Tan
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0277792 (2022)
Objectives & backgroundAnonymous live organ donors or unspecified donors are individuals willing to be organ donors for any transplant recipient with whom they have no biological or antecedent emotional relationship. Despite excellent recipient outco
Externí odkaz:
https://doaj.org/article/ac52e3d01c364ae3a782a690c984806b
Autor:
Darren Jun Hao Tan, Wen.Hui Lim, Jie Ning Yong, Cheng Han Ng, Mark D. Muthiah, Eunice X. Tan, Jieling Xiao, Snow Yunni Lim, Ansel Shao Pin Tang, Xin Hui Pan, Tousif Kabir, Glenn K. Bonney, Raghav Sundar, Nicholas Syn, Beom Kyung Kim, Yock Young Dan, Mazen Noureddin, Rohit Loomba, Daniel Q. Huang
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:1475-1484
Down-staging is commonly used to select patients with hepatocellular carcinoma (HCC) beyond Milan criteria (MC) for liver transplantation (LT), but outcomes are heterogenous. We aimed to estimate pooled down-staging success rates, HCC recurrence, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139be08f8a874b0676cd08cf37710deb
https://doi.org/10.1016/j.cgh.2022.02.018
https://doi.org/10.1016/j.cgh.2022.02.018